Japan’s Pioneering ASO Drugs Showcase Domestic Innovation...

adicionou um novo artigo Health

2025-06-20 07:42:46

Japan’s Pioneering ASO Drugs Showcase Domestic Innovation Strength

The global oligonucleotide therapy market reached around USD 8.6 billion in 2023 and is projected to soar to approximately USD 30.5 billion by 2031, reflecting a spectacular 15.8% CAGR during 2024–2031. Mid range forecasts project growth from USD 5.6 billion (2024) to nearly USD 9.8 billion (2029) a 12–14% CAGR highlighting a robust and multi‑year expansion trajectory. Sample...

0 Comentários 0 Compartilhamentos 55 Visualizações 0 Anterior